Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × Doxorubicin × Clear all

NCT04203641 2025-05-06

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Phase 1/2 Terminated

Gastrointestinal

Pancreatic Neoplasms